Search results
Results from the WOW.Com Content Network
The Wisconsin Controlled Substances board has authority to reschedule cannabis pursuant to the rule-making procedures of ch. 227. [144] Drafters planned to submit a petition to the Controlled Substances Board in early 2012. In 2018, Wisconsin voters approved non-binding referendums to legalize medical or recreational marijuana. [145]
The Biden administration plans to reclassify marijuana for the first time since the Controlled Substances Act was enacted more than 50 years ago.
A senior official at the US Department of Health and Human Services has called for easing restrictions on marijuana by reclassifying it as a Schedule III substance in a letter to the Drug ...
The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, The Associated Press has learned, a historic shift to generations of American drug policy that ...
The drug or other substance has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug or other substance under medical supervision. The complete list of Schedule I substances is as follows. [1] The Administrative Controlled Substances Code Number for each substance is included.
Since the Controlled Substances Act of 1970 classified marijuana as a Schedule I drug, until the passage of the 2018 United States farm bill, under federal law it was illegal to possess, use, buy, sell, or cultivate cannabis in all U.S. jurisdictions. As a Schedule I substance, the highest restriction of five different schedules of controlled ...
Marijuana is currently classified as Schedule I, reserved for the most dangerous controlled substances, including heroin and LSD. In 2022, President Joe Biden asked US Health and Human Services ...
The bill also fully removed or "descheduled" low-THC cannabis products from the Controlled Substances Act, where they had been listed as Schedule I drugs since the CSA's inception in 1970. [3] [11] 2022: The Medical Marijuana and Cannabidiol Research Expansion Act is signed into law to allow cannabis to be more easily researched for medical ...